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ABSTRACT: From 535 endomyocardial biopsies (87 
heart transplant recipients) 283 cell cultures could be 
generated. All cultures tested contained T lymphocyte, 
and it~ most cases CD4 was the predominant phenotype 
at any time postrransplant. A significantly higher propor- 
tion of CD8-dominated cultures was found among cul- 
tureS from biopsies without myocytolysis. 
In the first 3 months post transplant 57% of cultures 
showed cytotoxicity against both class I and class II mis- 
matched onor major histocorupatibility complex (MHC) 
antigens, changing to an incidence of 33~ at 
> 90 day:. This proved to be due to a significant decrease 
in the number of cultures with human leukocyte antigen 
class ]]-directed cytotoxicity. 
This study shows that early after transplantation a 
heart ransplant is infiItrated with activated onor-specific 
cytotoxic T cells which recogr.ize a broad spectrum of 
mismatched donor MHL antigens, and that in time this 
spectrum becomes more restricted. Human lmmunolog~ 
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ABBREVIATIONS 
B-LCL B-lymphoblastoid cell line 
CML cell-mediated lFmpholysis 
CTL cytolytic T ]ymphucytes 
t/MB endomyocardial biopsy 
EBV Epstein-Barr virus 
FACScan fluorescence-activated cell scan 
HLA human leukocym antigen 
IL-2 interleukin-2 
MHC major histocompatibility complex 
NK natural killer 
PBMC peripheral blood mononuclear 
cells 
PHA phytohemaggtutinin 
TCR T-cell receptor 
INTRODUCTION 
The diagnosis of rejection after clinical heart transplan- 
tation is based on histologic riteria [1]. Therefore en- 
domyocardial biopsies (EMB) are taken at regular inter- 
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vals after transplantation. This provides us with the 
opportunity to culture graft- infiltrating cells which 
makes it possible to evaluate growth patterns, pheno- 
typic composition, and function of these cells both in 
periods efgraft  stability and during rejection. TEe biop- 
sies were cultured in interleukia-2 (IL-2)-conditioned 
culture medium in the presence of irradiated autologous 
peripheral blood mononuclear cells (PBMC) as feeder 
cells, thereby assuming that only in vivo-acdvated lym- 
pkocytes will proliferate [2, 3]. Neither donor nor 
third-party cells were added within the first 3 weeks of 
cukure to avoid in vitro activation. In the present re- 
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port, we describe the phenotypic and functional charac- 
teristics oflymphocytes grown from EMB, and the rela- 
tion of these findings with time after transplantation a d 
histopathological diagnosis. 
METHODS 
Patients. We studied 535 biopsies from 87 heart trans- 
plant recipients transplanted between January 1985 and 
February 1989. During this transversal study we re- 
ceived 2 to 18 EMB from each patient (median 4). EMB 
were taken 5 to 1587 days (median 114) after transplan- 
tation. All patients had received preoperative blood 
transfusions and all received cyclosporine and low-dose 
prednisone only as maintenance immunosuppression. 
Their actuarial graft survival at 3 years was 89%. Acute 
rejection episodes, i.e., biopsy-proved myocytolysis, 
were treated with bolus steroids or with a 2-week 
course of a polydonal rabbit antithymocym globulin 
preparation in case of ongoing rejection. In the early 
posttransplant period serial biopsies were obtained at 
weekly intervals. Later EMB were taken less frequently, 
declining to once every 4 months at 1 year. After an 
acute rejection episode the next biopsy was taken 1 
week following rejection therapy. During right ventric- 
ular catheterization four or five biopsy samples were 
obtained. Three or four samples were used for histolog- 
ical evaluation, and one was placed in RPMI-1640 for 
tissue culture. The histological rejection grade was as- 
sessed according to Billingham's criteria [ 1]: grade O: no 
evidence of rejection, no infiltrate; grade 1: mild infil- 
tration of mononuclear cells, endocardial nd interstitial 
edema, diffuse perivascular and endocardial infiltration 
with pyroninophilic lyraphocytes; grade 2: moderate re- 
jection, perivascular, endocardial, and interstitial infil- 
trates with pyroninophilic lymphocytes, focal myocyto- 
lysis (necrosis); grade 3: severe rejection, vessel wail 
and myocyte necrosis with interstitial bleeding, intersti- 
tial infiltrates with polymorphonuclear cells and 
pyroninophillc lymphocytes (this rejection grade was 
not observed in our study); grade 4: resolving rejection, 
active fibrosis, some small nonpyroninophilic lympho- 
cytes, some plasma cells, and hemosideria. 
Culture method. Each biopsy was divided into two or 
more fragments and placed into two or more wells of a 
96-well roundbottom tissue culture plate (Costar 3799, 
Cambridge, MA) with 200/xl culture medium in the 
presence of 105 irradiated (40 Gy) autologous PBMC as 
feeders. Culture medium consisted of RPMi-1640- 
Dutch modification (Gibco, Paisley, Scotland) supple- 
mented with 10% vol/vol lectin-free Lymphocuk-T-LF 
(Biotest GmbH, Dreieich, FRG) as exogenous ource 
of 11,-2, 10% pooled human serum, 4 mM L-glutamine, 
100 IU/ml penicillin, and i00 g.g/ml streptomycin. 
PBMC were isolated by Fico'd-Isopaque (¢ ---- i.077) 
density-gradient centrifugafion. Biopsy cultures were 
grown a~ 37°C in a humidified CO2 incubator. Halt" the 
culture medium was refreshed every 2 to 3 days. When 
growth was observed the coments of several wells of a 
culture were pooled and transferred to more welis when 
sufficient cell density was reached (10 ~ to lff" cells/rob. 
When growth was sRowing down or cell death wm ob- 
served the cultures were restimulated by adding either 
10 ~ irradiated (40 Gy) donor spleen ce]ls/well or, whe~ 
available, 10 i Ebstein-Barr virus {EBV)-transformed 
donor ceiis/wetl (irradiated with 80 Gy). This was not 
done in the first 3 weeks of culture. 
8-1ymphobl~toid cell lines (B-LCL) originated from 
infection of fresh PBMC or spleen cells with EBV ob- 
tained from the marmoset teE1 line B95-8 as described 
by Moreau et al. [41. These cel~ fines were cukured in 
RPMI !640 supplememed wit]~ 10q~ hear-inactivated 
fetal calf serum (SeraLab, Sussex, EngtandL 
T-lymphoblastoid cell lines were obtained by cukur- 
ing PBMC or spleen cells in RPMI t640 supplemented 
with 5% pooled human serum, 5~c voltvol Lymp~o- 
cult-T (Biotest), and I% phytohemaggtutinin (PHAL 
K562 was cultured in RPMI [6q0 with 10% heat- 
inactivated fetal calf serum. 
Phe~totypic analysis. Surface differentiation antigens 
were analyzed by two-color flow cytomerry after sta/n- 
ing with monoclonal antibodies directed aga/nst CD3 
tanti-leu4) as a pan mature T-tel! marker, w'r31 as a 
marker for the c~/fl chain of the T-cell receptor ~TCR), 
and CD8 tanti-leu2) and CD4 (ami-leu3) as T-ceil sub- 
set markets. CD16 (anti-leu 1 i) and CD56 (anti-leu 19) 
were used as markers for natural killer iNK) celas. Anti- 
bodies were direcdy conjugated to fluoresceirte (HTC) 
or phycoerythrin (PE) (Becto~ & Dickinson, Mount~fin 
View, CA). The presence of r/8 T cells was demon- 
strated by the monodonM anra-TCR-r/6-1 (clone 11 F2) 
[5t by an indirect fluorescence technique. Cells were 
stained by incubating 0.5 to 1 × 10 ~ cells in 50 #1 
Hanks balanced salt solution (Biocbrom KG, Berlin} 
supplemented with 1% bovine serum albumin a.ud 
0.1% sodiumazide for 30 rain at room mraperamre with 
two antibodies conjugated to different fiuorochromes. 
After washing, cells were analyzed on a fluorescence- 
activated cell scan (FACScan) flow-cytometer (Becton 
and Dickinson). 
Cell-mediated cytotoxicity. Cytotoxiciry was tested 
against donor cells and a panel of unrelated target cells 
sharing one or more human leukocyte antigens (HLA) 
with the donor. Fifty-nine bulk cultures could be tested 
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before resrimularion with aIlogeneic ells. The remain- 
ing cultures had to be restimulated Jn order to obtain 
sufficient numbers of cells. No effect of restimulation 
on cell-mediated lympholysis (CML) specificity could 
be demonstrated after repeated testing. Three types of 
target cells were used: PHA-blasts (HLA class I targets), 
B-LCL (class I and II targets), and the K562 cell line for 
assessment of NK cell activity. A standard 4-hr 51Cr- 
release assay was performed [6] with one effecmr-rarget 
ratio of 20: 1. When possible E:T ratios varying from 
1.25 : 1 up to 80 : 1 were used. Target cells were incu- 
bated for ! I/2 hr at 37°C with 200 t~Ci 5tCr (Na,CrOt 5 
mCi/ml, specific activity 350-600 mCi/mg chromium, 
Amersham, UK). ~ICr-laheled target cells (2.5 x I0 ~) 
were mixed with effector cells in 0.2 ml of culture me- 
dium in 96-welt roundbottom tissue culture plates. The 
plates were centrifuged at 600 g for 1 min, incubated at 
37°C, and superaatants were collected after 4 hr (Ska- 
tron AS, Lier, Norway). Spontaneous chromium release 
was determined by incubation of targets in 0.2 ml cut- 
ture medium, and maximum release was obtained by 
adding 10% Triton X-lO0 detergent (5% vol/vol solu- 
tion in 0.01 TRIS buffer) to the targets. Experimental 
release was measured and specific lysis was calculated 
with the following equation: 
Specific lysis = I00 x 
Experimental release - spontaneous release 
Maximum release - spontaneous release 
A CML assay was considered positive when the percent- 
age specific lysis of  donor antigen-bearing target cells 
exceeded 10% and the slope of a gra1~h was positive [6]. 
Series of double dilution studies revealed that lysis per- 
centages of less than 10% are within the variation range 
of the assay (data nor shown). 
For statistical analysis of all data a chi-square test, 
with Yates correction when appropriate, was per- 
formed. 
RESULTS 
Generation of lymphocyte cultures. In total 283 lympho- 
cyte cultures were established from 535 EMB (53%), 
From the majority of patients (72/87) cells could be 
successfully grown from at least one biopsy. From the 
remaining 15 patients only a few biopsies were available 
and these were almost always taken more than 1 year 
after transplantation. Cell growth was most successful 
from EMB taken in the second and third postoperative 
months (Table I). After 3 months a significant decrease 
of the growth percentage was observed (p q 0.005 
when compared to all EMB taken in the first 3 months). 
Table 2 shows that the rate of establishing ct~ltures i  
positively correlated with increasing histological rejec- 
tion grade. Even when no mononuclear cells were de- 
tected by histology (grade 0 or 4) cell growth was ob- 
tained in 37% of the cas.~.s. These grade 0/4 biopsies 
showed the highest growth percentages between 11 and 
180 days after transplantation with a peak of 64% in the 
second and third posto-erative months and a decline to 
33% after 180 days (p < 0.01 when the pe-lod between 
I1 and t80 days is compared with > 180 days). EMB 
showing histological signs of infiltrate (grades 1 and 2) 
yielded more cultures than grade 0/4 biopsies indepen- 
dent of the time after transplantation. After the first 90 
days a decline of the growth rate of grade I EMB was 
observed (p < 0.01). Grade 2 EMB always showed high 
growth percentages (Table 2). 
Phenotypicanal~sis. Flow cytometric analysis of cell sur- 
face molecules of  200 cultures howed that the 
TABLE I Culture results and numbers of cultures analyzed for 
phenorype and cytotoxicity in relation to time after 
transpiamatio n 
No. EMB 
0-10 30 3t 7 ~23) 6 4 
ll-}O 31 80 46 {58) 39 24 
31-90 32 t25 91 (73) 74 49 
91-180 34 96 55 (57) 36 25 
181-365 32 83 31 (37) 21 7 
>365 50 120 53 (44) 24 t7 
Total 87 535 283 (53) 200 126 
Days after No. Analyzed for Tested 
transplantation patients Obtained Growing (%) phent~type in CML 
C'/totoxic Cells Infiltrating Heart Transplants 53 
TABLE 2 Relationship of successful cell growth from EMB with histological rciection 
grades (Bi!lingham's criteria) in different ime intervals after transplantation 
Grade 0, 4" Gradt- 1 Grsde 2 
Dv, tys post 
transplam No. EMB Growing ~¢Ye ) N*~ EMB Growing (Cf ~ No- EMB Growing (G: I 
0-10 26 3 112) 5 .~ ~80~ l) 
11-30 25 11} (-io~ 46 30 (65) 9 f~ (67~ 
31-90 25 I6 (64) 83 60 c-r2) 17 15 I8~ 
91-180 26 I4 (54) 59 52 154~ It 9 ¢82~ 
I81-365 42 9 121) 41 22 15,t1 l) 
>365 75 29 ~39P 44 23 (52~ I 1 
Toefl IEMB 219 81 137) 278 171 162) 38 ~,t ~82! 
No. patients 78 52 64 5 ~ 2~ 20 
"Grades 0 and 4 FAMB were grourred toget~t,-¢ because these shrew equal/zmwth percentages. 
(89.5%) exclusively consisted of cells carrying the CD3 
determinant, Almost all CD3 + cells were WT31 +. The 
CDzi/CD8 makeup of the T cells in 200 cultures is 
shown in Table 3. Twenty-nine cultures contained only 
CD4 + T cells and 15 consisted of CD8 ~ cells only, In 
three cases exclusively CD4-CD8-  cells were found 
(TCR r/S* cells, described below). All except hree re- 
cipients whose EMB cultures could be tested for pheno- 
type had multiple mismatches for HLA class I and II 
with their donors. The cultures from one patient with 
only one class II and no class I mismatches contained 
only CD4 + cells (three EMB). Five E_bIB from two 
other patients of whom oue had one mismatch on the B 
locus and the other an additional mismatch on the A 
locus yielded pure CD8 cultures as well as mixed cul- 
tures. One culture even contained CD4 + T cells only, 
No significant difference in the number of  mismatches 
between donor and recipient could be demonstrated 
between patients supplying pure CD8 or pure CEM cul- 
tures (mean number of mismatches: 2.80 versus 2.85 
for HLA A,B and 1.60 versus 1.45 for HLA DR, re- 
spectively). In the remaining 1.53 cultures bo~h CD& 
and CD8 ~ cells were found and the greatest fraction 
comprised culture7 with CD4 as the predominant phe- 
notype at any time after transplantation. Again, r~o sig- 
nifieam relation with the number of mismz.zehes w~s 
fo,md, in the cultures originating from biopsies wL'h 
myocytolysis the preponderance of CD4 celts w~ more 
striking and a significantly lower proportion of CDg- 
dominated cultures was found (Fig, 1, p < 0.025), 
In 16 cultures from ~3 patients CD3+WT3 l-1 IF2 ÷ 
cells (TCR r/S*) were found in amounts var;ling from 
5% to 100% of the cultured cells (median 27%). The 
EMB were taken between 29 and 1324 days lposttrans- 
plant (median 624 d%,s). In four cases (four different 
patients) the rS* cells dimly expressed CD8. The re- 
maining cukures only contained CD4- CDS- ~'~+ cells. 
We found ¢8 + cells significandy more often ~t more 
than 1 year after" transplantation (11/24 versus 5/~.76 
phenoryped cultures, p < 0.0Ol). Three of four dimly 
TABLE 3 Predominant phenotype of 200 cultures (59 patients) in relation to time after transp]ar~taton 
Single<eli-type 
Mixed cultures tn) cultures In) 
Days 
posttransplant >61)~.~, CD4 CD4 ~ CD8 >60% CD8 >60~,¥ CD4 CD8 Only CD-J Only CD8 Only CD4 CD8 
0-30 18 l~ 8 0 3 3 0 
51-90 2~ 15 19 0 12 3 0 
91-180 10 5 6 1 ! I ~ 0 
>180 17 5 9 2 3 6 3 
Total EMB ?O 38 42 5 29 I 5 3 
No. p~ttients 42 25 28 3 211 15 3 
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CD8* ¢8 ÷ containing cultures originated from EMB 
taken more than 1 year posttransplant. 
CD3-  ceils were found in 21 cultures (19 patients). 
In these cultures 7% to 96% of cells expressed CDI6 
and/or CD56 antigens (median 24%) and EMB were 
taken from 6 to I587 days posttransplant (median 148 
days). In seven cultures from various patients the NK 
cells were dimly CD8 positive, six of them were grown 
from EMB taken in the first posttransplant year. We 
detected significantly more NK cells in cultures from 
biopsies taken more than 1 year after transplantation 
compared to the first posttransplant year (8/24 versus 
t 3/176, p < 0.001). These cells were never grown from 
biopsies with myocytolysis. 
Call-mediated cytetoxicity. From 126 EMB (47 patients) 
sufficient cells were generated to test cytotoxic func- 
tions (Table 1). Kilt of donor antigen-bearing target 
cells was found in t06 cukures. Table 4 shows the 
results of the specific CML reactivity. Donor-specific 
cytotoxicity against HLA class I antigens (either alone 
or in combination with reactivity against class II) was 
found in 75% of the cases, and against class II antigens 
(alone or in combination with class I) in 56%. Reactivity 
against both class I and class II antigens was detected in 
48% of the bulk cultures and restricted reactivity (i.e., 
against either class I or class II antigens only) in 37%. 
Cultures originating from grades l and 2 EMB showed 
multisp-r;.]c CML reactivity significantly more often 
when compared to grade 0 EMB cultures (Table 4, p < 
0.01), while most negative CMLs were found among 
grade 0 EMB cultures (p < 0.005, compared to grades 1 
and 2 EMB cultures). 
FIGURE 1 Proportion of cultures dominated by (>60%) 
CD4 + , CD8 ÷, or CD4-8- cells or containing equal amounts 
of CD4 + and CD8 ÷ ceils. The phenotypic composition of 173 
cultures derived from EMB without myocytolysis (histology 
grades 0 and 1) was compared with that of 27 cultures from 
EMB with myncytolysis (grade 2). During acute rejection a 
decrease in the number of cuttures containing predominantly 
CD8 + cells was observed (p < 0.025). 
In time a significant shift was observed from a pre- 
dominantly muhispecific to a more restricted CML pat- 
tern when the cultures from EMB taken before and 
after 3 months were compared (Table 4). This proved to 
be due to a significant decrease in the number of cul- 
tures with HLA class il-directed cytoroxicity derived 
from grades 1 and 2 EMB (p < 0.01). This decrease was 
not accompanied by a significant change in the pheno- 
typic composition of the bulk cultures as CD4 remained 
the predominant phenotype at any time after transplan- 
tation, regardless of  the CML specificity of the cultures. 
Similar phenotypic ompositions were found in cultures 
with HLA class l-directed cytotoxicity and in cultures 
without donor-directed CML reactivity. 
Kill of the K562 cell line was observed in 26/107 
tested bulk cultures. In 22 of these allospecific reactivity 
was also found. NK  reactivity did not show a significant 
relation with time after transplantation or histological 
rejection grade. Only 7/26 cultures contained cells with 
the CD16 and/or CD56 phenotype of which two had 
70% and 64% CD8 aim* NK cells next to CD4 b~igb:+ T 
cells. One of the latter cultures showed donor-specific 
killing next to kill of K562, the other culture did not 
show donor-specific lysis, but only killed K562. Five of 
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TABLE 4 CML reactivity of 126 bulk cultures (47 patients) against panel cells sharing either 
FILA class I or class II with the donor 
Grade 0. 4 Gr i t s  1 a~d 2 To~a~ 
CML specificity n 4~" ) u ( ~,~ t ~: (¢.: 
<90 days n ~ = 18 ~ = 59 e = 77 
Class I only 7 (39} 10 ( I ~! I7 (22~ 
Class II only l (6) 5 ~8) 6 ~$) 
Both class I and 11 5 (28) 39 c65~ -~,~ (57~ 
Negative 5 (28)  5 (8~ 10 (151 
>90 days n - 16 J~ - 33 n ~ 49 
Class 1 only 4 (25; 14 ~42) 13 ~Sv~ 
Class II only 2 (13! } tg) 5 (lO) 
Both class I and II 4 ~25) 12 f~,6) 16 (33) 
Negative 6 (58~ 4 , t2; 10 ; !3) 
Total n - 34 n - 92 a = 126 
Class 1 only 11 ~ ~2) 24 ~26~ 35 (28) 
Class II only 3 (9) 8 ~9~ 11 (9: 
Both clas~ 1 and 11 9 (26) 51 i35) 60 !48~ 
Negative 11 (32) 9 l I0) 20 1161 
After 90 days, postttm't~plaamtloa a significartt decrease in the numb~.r of cultures with g~ncrdized rea:-,~ir:¢ vva~ fo~ d. This proved to b~ due 
to a decrease in the number of cultures with HLA class l I-directed cytotoxicity aerived from grades I a~d 2 EM B Ifrcm 44159 to 15/33 after 
90 da~cs, p < 0.01 }. Most negative CML~ were found among rade t) EMB calrure~, (p <: [).(~O5 ~omp~ed to grades 1 and 2 EMB cuh~resL 
= p; = numbers of cultures, 
eight tested CD8- NK ceil containing cultures showed 
NK reactivity, two did not lyse donor antigen-bearing 
panel cells. All four tested cultures with high percent- 
ages of NK cells (>55%) killed K562. 
Rejectors rersus nonrejectors. The group of 87 heart trans- 
plant recipients consisted of 59 patients who had experi- 
enced one or more rejection episodes (rejectors) and 28 
pat ients  who  had  never  re jec ted  the i r  g ra f ts  ( rxonre jec -  
tots). There was no significant difference in the number 
of HLA mismatches between donor and recipient in 
both populations (mean number of mismatches 2.78 
versus 2.79 for HLA A, B and 1.41 versus 1.21 for 
HLA DR, respectively). 
Generation of lymphocyte cultures from EMB from 
both patient groups showed similar growth patte~.~ in 
relation to time after transplantation a d histologica~ 
rejection grade (Table 5). Cultures from biopsies from 
nonreiecmrs more ofmn showed a predominance of
CD8 ÷ T ceils than EMB cultures from reiectors ~Table 
6, p < 0.025). This was due ,o the significandy higher 
proportion of CDS-dominated cultures derived from 
histology grade 1 EME in the noareiectors (p < 0.005 
compared with grade 1 EMB cukures from rejectors), 
especially in grade l EblB preceding a grade 0 biopsy. 
No significant relation wkh time after transplantation 
could be demonstrated. 
CML panel reactivity of EMB cultures f~om rejectors 
changed from a predominantly mukispecific pattern in 
the first 3 months to a more restricted cytotoxicity 
TABLE 5 Culture results of EMB from reiectors and nonrejectors in relation to time 
after transplantation 
Rei~'ctorS Nonr~*ielctors 
Days post Growing Growing 
transplant No- patients No. EMB n (C~t No. patients No. EMB tt (~  
0 -10  17 17 5 (29) 13 1.4 2 (14) 
1 t -30  18 44 25 (57) 15 56 21 (58) 
51-90  20 72 53 (74~ t2 55 ~8 ~72) 
91-180  24 73 42 ~58) 10 25 13 457? 
181- ]65  23 59 25 (42) 9 24 6 ~25) 
>365 36 87 41 147) 14 33 t2 (36) 
TotM 59 352 191 (54) 28 183 92 t50) 
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TABLE 6 Predominant phenotype of EMB cultures from 59 rejectors and 28 
nonrejectors and relationship with hi,tological rejection grade 
No. cultures 
Histological reiecrion 
grade >609f CD4 CD4 = CD8 >611% CD8 >60% CD4-CD8 Total 
Rejectors 0 13 3 13 3 32 
l 39 20 L6 2 77 
2 I6 8 2 1 27 
Total 68 31 31 6 136 
Nonreiectors 0 14 1 4 0 19 
1 17 6 22 I) 4 5 
Total 31 7 26 g 64 
thereafter (Table 7). In the first 3 months 67% of cul- 
tures were cyrotoxic against both HLA class l and class 
11, which decreased .'o 36% there=fret (p < 0.01). This 
was mainly due to a decrease of HLA class II-directed 
cytotoxicity. In the nonrejectors no significant decline 
in the fraction of cultures howing multispecific cytotox- 
icity was found. In the first 3 postoperative months the 
number of cultures exhibiting cytotoxicity against both 
HLA class I and lI was lower than in the rejectors. After 
3 months no significant difference in cytotoxic specifici- 
ties between rejectors and nonreiectors could be dem- 
onstrated. 
DISCUSSION 
The present study shows that donor-specific cycotoxic 
tymphocytes can be grown from EMB taken at any time 
after transplantation, especially from grades I and 2 
EMB. We also showed that CML panel reactivity 
changed in relation to time from a predominantly 
multispecific pattern to a more restricted one, which 
proved to be due to a significant decrease in the number 
of cultures with HLA class IT-directed cytotoxicity. No 
corresponding change was observed in the phenotypic 
composition as CD4 remained the predominant pheno- 
type in most cultures at any time after transplantation. 
This could mean that only a small fraction of the b'm- 
phocytes in the bulk cultures i  responsible for the CML 
specificity, or that the responsible cytolytic T lympho- 
cytes (CTL) have high affinity antigen receptors that do 
not require CD4 or CD8 molecules to stabilize antigen 
binding [7]. MacDonald et al. [8] showed that resis- 
tance of routine CTL clones to inhibition with anti-CD8 
monoclonal ntibodies correlates with in vivo priming 
TABLE 7 CML specificity of 87 buik cultures from rejectors (33 patien-s) and 39 
cultures from nonrejectors (14 patients) 
Rejo:tors Nonrejectors 
CML specificity n (%) n (%) 
<90 d~ys 
>90 days 
#'~ = 48 n = 29 
( 18 patients) (12 patients) 
Class I only 7 (15) t0 (34) 
Cias~ [1 only 2 (4) 4 (14) 
Both class l and II 32 (67) 12 (41) 
Negative 7 ( I 5) 3 t LO) 
,t = 39 n = 10 
(23 patients) (6 patients) 
Class I only L4 (.~6) 4 (40t 
CLips II only 5 (I3) 0 (01 
Both class I and [ I  14 (361 2 (20) 
Negative 6 ( 15 ) 4 (40) 
In the rcj~cror~ a significant declit~e in the number of cuhures with geaeralizccd r¢=~ti~ity was found (32t4~ versus L4/~6, p < 
0.OI;*. TMs was rnainIy due to a decrease of HLA dass l]-dieecmd cymtoxidty (34/4fl ar <~J days versus 19/39 at >90 daFs). 
In the nonre]ectors this was less apparent. 
• ~ = numbers of  culture:i, 
Cymtoxic Cells Infiltrating Heart Transplants 57 
of these cells. Whether T cells carrying high affinity 
TCR preferentially home in the anograft has not been 
investigated yet in the human. 
Another finding in the present study was the h/gher 
incidence of NK cells and TCR ¢/8 + cells among cul- 
tured graft infiltrating cells at 1 year after transplanta- 
tion which, with one exception for the ~'8 + cells, only 
originated from EMB without myocytolysis. The role of 
these cells in an allograft is not clear. They might play a 
role in maintaining graft stability or just be attracted to 
the site by lymphokines produced by major histocom- 
paribility complex (MHC)-restricted cells, macro- 
phages, or other types of co|Is. Whether ~rB* cells or NK 
cells play a role in the development of chronic reiecdon 
is still under investigation. 
Part of the cultures dimly expressed CD8. These 
CD8 molecules did not seem to function as an accessory 
molecule mediating class I-directed killing, for none of 
the bulk cultures containing high percentages of these 
ceils showed donor-specific tysis. Some of the :,8 ~ cell- 
containing cultures were cloned. Neither donor-specific 
cytotoxicity nor proliferation could be demonstrated in 
any of the CD8 d~"* or the CD8- ,rB" clones [9]. Fur- 
thermore, after culture ofCD8 + clones from one biopsy 
in recombinant IL,2-containing medium the CD8 ex- 
pression disappeared (data not shown). The CD8 
molecule might have been induced on the cells by the 
culture conditions in medium with a mixture of lympho- 
kines, including 1L-4. It has been demonstrated before 
that CD8 b*~gh~ can be induced on CD4 + tymphocyces 
under the influence of IL-4, and that this molecule can 
be functional in class l-mediated killing [10]. 
Several comparative studies of the CD4/CD8 profile 
of the T cells seen in situ (immunoperoxidase staining) 
and that of the lymphocyte cultures showed that the 
CD~/CD8 composition of lymphoid cells cultured from 
biopsies had a good correlation with the actual situation 
in the graft [11, 12]. The present study shows that most 
biopsies yield mixtures of CD4* and CD8- cells with 
CD4 as the predominant phenotype in most cases, 
which is in agreement with data of Fung eta/. [13]. [n a 
limited number of observations others found CD8 as 
the predominant T-cell subset in cultures from renal or 
cardiac biopsies. This is thought o be due to the use of 
azathioprine in their immunosuppressive protocols [2, 
12, 14]. Like the present study, no relation between 
predominant phenotype and the number of HLA mis* 
matches between donor and recipient was found. 
We showed that a lower rejection grade was associ- 
ated with a higher number of CD8-dominared cultures. 
Also in patients who never experienced acute rejec- 
tions, significantly more CD8 + cells were found among 
infiltrating ceils. These observations could suggest that 
these cells play a mitigating role in the rejection pro- 
tess. An alrern~tive explanation for the grea~er pzedo~,.- 
ination of CD4 ~ cells during reiecrion migh.~ be t~a~. it is 
a consequence of higher HLA class H expressian on 
graft tissue. We could not confirm the finding of Weber 
eta/. [I5], that cell growth from histo]ogica~y negative 
EMB obtained in the first ~stoperadve month had a 
positive correlation with the c~mulative incMenee of 
subsequent histological rejection. 
The lower incidence of HLA c l~  H-directed cyto- 
toxicity after the ~irst 3 months in the present study is in 
~reement with an extensive survey ~ong renal trans- 
plant recipients [16]. This survey showed that the effect 
of DR matching on the relarlve risk for graft f~iinre wm 
high in the first 5 months, thereafter the effect disap- 
peared. On the other hand, the matching effect of HLA 
class [ antigens was evident during the whole follow-up 
period. In the present s~udy we showed that class i- 
directed cytotoxiclry remained relar~vely co~szant in 
time after transplamadon. Several investigators have 
demonstrated the induction of MHC class i ~ntigens on 
myocytes and increased expression of cJass I and If on 
interstitial structures during rejection [17-I9], which 
makes the graft tissue more culnerab]e to specific ce]~- 
mediated lysis [20]. In some studies MHC expression i  
the atlograft returned to t~ormal after successful rejec- 
tion treatment [18], at~hough others found persistence 
of expression of donor-type c-lass 1I determinants on 
interstitial structures of the donor heart 1 and 2 years 
after trmasp]antation [17, 2IJ. It has been shown tha~, to 
a certain degree, HLA class I1 expressing dendritic ells 
of donor origin are replaced by recipient bone marrow 
derived cells [17, 22, 23]. This may contribute to the 
lower incidence of donor-class H directed cytotoxici~. 
In vitro experiments have shown that lymphokine~, par- 
ficuiarly interferon % regulate the induction and upre- 
gulation of(donor) MHC expression on graft tissue and 
leukocyte binding and penetration through the endo- 
thelium [24, 25], and that ir~ me early posttr~splant 
period, when the incidence of acute rejection is high, 
lymphokine-producing ceils are numerous i~ the graft 
[26]. This is in agreement with our finding that the 
highest growth rates of aIloacdvaced lymphocytes were 
found in the second and third months after transplanta- 
tion. This peak of growth was observed in the rejector 
as well as nourejector patient groups. Apparently the 
presence of activated lymphoaytes in the graft does not 
a/ways lead to Mlograft destruction. We found that ctfl- 
lures from nonrejector EMB token in the first 3 postop- 
erative months generatly show a more restricted c~-to- 
toxicity than those from rejectors, which indicates that 
in this period the number of a[loreactive CTL clones in 
vivo is lower in nonrejectors. Tl~is might have conse- 
quences for the development of myocyte ~njury. 
Many speculations h.~ve been made about possible 
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mechanisms involved in stabilization of the graft and on 
the role different kinds of cells and lymphokines play in 
this process [27-30]. Mechanisms that have been pro- 
posed to be involved are clonal deletion of antidonor 
alloreactive cells or specific suppression of aUoreactive 
T ceils. From earlier studies on circulating mononuclear 
cells CML hyporesponsiveness [27, 28] and a reduction 
in the frequency of donor-reactive CTL precursors [29] 
h~ve been reported in patients with well-functioning 
geaf~, In contrast, another study on a patient with a 
wel!-fimctioning kidney graft showed that the frequency 
of donor-specific CTL precursors was still high, but 
these cells were not operational in rive [30]. We 
showed that biopsy-grown lymphocyres from aliografts 
without acute rejection often still contain donor-di- 
rected cytotoxic ells. The mechanism that plays a major 
role in controlling the immune response in rive is still 
unclear. Fm'ther investigations will address the question 
of whether specificity of graft infiltrating cells becomes 
more restricted because of diminished MHC class I 
and/or class II expression on donor heart issue, or if it 
is caused by deletion or suppression ofcertain allospeci- 
fic CTL dories, irrespective of the degree of allograft- 
MHC expression. 
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